alyve medical logo

Alyve Medical Announces Publication of Clinical Trial on Neuralign S in the Treatment of Posterior Shoulder Instability


Study confirms the clinical benefits of incorporating treatment with Neuralign S into rehabilitation protocols for patients with posterior shoulder instability.

DENVER, COLORADO, UNITED STATES, October 26, 2023 / — Alyve Medical Inc., a global medical technology company and leader in data-driven joint kinematics tools and personalized neuromuscular electrical stimulation (NMES) technologies, announced today the publication of results from an independent multi-center randomized controlled trial evaluating the safety and efficacy of Neuralign S™ (formerly known as Shoulder Pacemaker) in the treatment of functional posterior shoulder instability. The results were published in the Physical Therapy & Rehabilitation Journal (PTJ), the official journal of the American Physical Therapy Association (APTA).

Read More